W
WAVEMAN · COMPANY
QTRX · Quanterix Corp
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

QTRX

Quanterix Corp
MEDICAL DEVICES · LABORATORY ANALYTICAL INSTRUMENTS · CIK 0001503274
C-SUITE BUYING · 1☆ WATCH
INSIDER NET · 180D
$296.0K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
2
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
81
13F, latest reported quarter
REVENUE GROWTH
+1.1%
XBRL, annual
NET MARGIN
-77.1%
CONVERSIONS · 180D
53
codes C/M, not in net · no price filed
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$296.0K over 180 days
+$286.4K over 90 days
more than 87% of Medical Devices
CONGRESS
no member of Congress has reported trading it
FUNDS
81 funds added or opened last quarter
more than 52% of Medical Devices
REVENUE
+1.1% year over year
below 70% of Medical Devices
MARGIN
-77.1% net margin
below 80% of Medical Devices
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
81 funds added or opened positions in the latest 13F quarter, of 134 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -40.1%
-40.1%12M
-46%-4%+38%+80%2025-092025-102025-122026-032026-052026-072026-09 2026-08-13 · DONNELLY WILLIAM P bought $211.7K2026-08-12 · DONNELLY WILLIAM P bought $74.7K2025-09-12 · Sriram Vandana bought $19.9K2026-05-12 · Meadows Benjamin bought $9.7K
INSIDER BUY
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders are net buyers of their own stock.
The record shows a net $296.0K bought by insiders over 180 days, 81 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
TMOPENROKBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDX
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Quanterix Corp insiders bought a net $296.0K of stock across 144 Form 4 purchases and sales, with 2 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
DONNELLY WILLIAM P
Director
BUY
2026-08-13
72,245.0
$211.7K
DONNELLY WILLIAM P
Director
BUY
2026-08-12
27,155.0
$74.7K
Meadows Benjamin
Chief Commercial Officer
BUY
2026-05-12
3,500.0
$9.7K
Sriram Vandana
Chief Financial Officer
BUY
2025-09-12
4,150.0
$19.9K
WALT DAVID R
Director
BUY
2025-06-13
123,990.0
$761.3K
144 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 139 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
First Eagle Investment Management, LLC
5,506,330.0 sh
$23.8M
BlackRock, Inc.
3,635,411.0 sh
$15.7M
Blue Water Life Science Advisors, LP
3,474,202.0 sh
$15.0M
Portolan Capital Management, LLC
1,899,308.0 sh
$8.2M
VANGUARD CAPITAL MANAGEMENT LLC
1,800,644.0 sh
$7.8M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Invesco NASDAQ Future Gen 200 ETF
$59.6K POSITION · AS OF 2026-02-28
0.4%
William Blair Small Cap Growth Fund
$2.5M POSITION · AS OF 2026-03-31
0.3%
Invenomic Fund
$2.4M POSITION · AS OF 2026-04-30
0.2%
Dunham Small Cap Growth Fund
$176.3K POSITION · AS OF 2026-04-30
0.2%
Ultra-Small Company Market Fund
$240.2K POSITION · AS OF 2026-03-31
0.2%
First Eagle Small Cap Opportunity Fund
$4.3M POSITION · AS OF 2026-04-30
0.2%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122023-09
REVENUE$138.9M$137.4M$122.4M—
GROSS PROFIT$65.0M$83.1M$74.2M—
OPERATING INCOME$-125.5M$-52.6M$-46.0M—
NET INCOME$-107.2M$-38.5M$-28.4M—
EPS (DILUTED)-2.51-1.00-0.75—
OPERATING CASH FLOW$-77.2M$-35.2M$-18.8M—
CASH$29.8M$56.7M$174.4M$201.3M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →